Breaking News Instant updates and real-time market news.

VRTX

Vertex

$129.19

-1.76 (-1.34%)

07:58
07/18/17
07/18
07:58
07/18/17
07:58

Vertex price target raised to $154 from $130 at Stifel

Stifel analyst Adam Walsh raised his price target on Vertex as he thinks that the data on its triple combo in the large het/min CF population will be positive. The analyst quotes an expert as saying that, given the absence of an approved therapy for the illness, equivalent efficacy results "would lead to high utilization among physicians." The analyst thinks that the stock could rise further on positive data, and he keeps a Buy rating on the shares.

  • 26

    Jul

VRTX Vertex
$129.19

-1.76 (-1.34%)

06/23/17
06/23/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) upgraded to Buy from Hold at Argus with analyst Joseph Bonner saying the company's fourth quarter results show that its cloud business is already having "some success." 2. RH (RH) upgraded to Buy from Hold at Deutsche Bank analyst Adam Sindler saying he believes there will be less revenue pull forward from its current inventory correction actions than is expected and he thinks the company, and the bulls, will continue to buy shares on any pull back, driving down its share count. Sindler raised his price target on the parent of Restoration Hardware to $66 from $45. 3. Novartis (NVS) upgraded to Equal Weight from Underweight at Barclays with analyst Emmanuel Papadakis citing better than expected CANTOS results. 4. AK Steel (AKS) and U.S. Steel (X) were upgraded to Buy from Hold at Deutsche Bank, while Century Aluminum (CENX) was upgraded to Hold from Sell. 5. Vertex (VRTX) upgraded to Buy from Hold at Needham with analyst Alan Carr saying he predicts Vertex will identify at least one safe and effective triple regimen for commercial launch by the end of 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/30/17
LEER
06/30/17
NO CHANGE
Target $74
LEER
Market Perform
Vertex acquisition is Gilead's best option, says Leerink
Gilead Sciences (GILD), with a declining Hepatitis C franchise and lackluster stock performance, needs a transformational acquisition soon to prop up its falling revenue and growth outlook, Leerink analyst Geoffrey Porges tells investors in a research note titled "Deja vu...Why VRTX Is Still Gilead's Best Option, & Might Restore $120/share." Shares of Gilead have been the worst performer in biotech this year and faces "potentially devastating revenue erosion in 2018," the analyst warns. He believes an acquisition of Vertex Pharmaceuticals (VRTX) would provide "one of the few options" for Gilead to offset the risks and "inevitable erosion" of its legacy product franchises. Porges admits, however, that management's comments continue to suggest that Gilead's "focus and interests are away from Vertex." Nonetheless, the analyst's preliminary merger analysis indicates that an acquisition of Vertex at a typical 20%-40% premium, or $153 to $178 per share, would prove to be "meaningfully accretive" to Gilead in the long run with an internal rate of return of 8%-10% for shareholders. His sensitivity analysis finds that Gilead could pay up to $230 per share for Vertex and still make the acquisition accretive by the second year. Porges has a Market Perform on Gilead with a $74 price target. Shares of Vertex are up 2%, or $2.76, to $130.00 in premarket trading.
07/10/17
JEFF
07/10/17
INITIATION
Target $155
JEFF
Buy
Vertex initiated with a Buy at Jefferies
Jefferies analyst Michael Yee initiated Vertex with a Buy and a $155 price target.
07/11/17
JEFF
07/11/17
NO CHANGE
JEFF
Jefferies fundamentally positive on Biotechnology, lists top picks
Jefferies analyst Michael Yee rolled out coverage of 12 Biotechnology names in a 550 page research report. The analyst is "fundamentally positive" on the sector, believing investor interest in large-caps will pick up "as the road to repair slowly continues." He believes the smid-cap space is "becoming a good stock-pickers' market." Yee's top picks in Biotech space include Celgene (CELG), Vertex (VRTX), Spark Therapeutics (ONCE), Prothena (PRTA) and Intercept (ICPT). The analyst's best picks in the smid-cap space are Spark, Prothena, Intercept and FibroGen (FGEN).

TODAY'S FREE FLY STORIES

TWX

Time Warner

$101.83

-0.37 (-0.36%)

, CMCSA

Comcast

$37.22

0.32 (0.87%)

18:56
10/22/17
10/22
18:56
10/22/17
18:56
Hot Stocks
Box Office Battle: 'Boo 2' wins weekend with $21.7M »

Lionsgate's (LGF.A)…

TWX

Time Warner

$101.83

-0.37 (-0.36%)

CMCSA

Comcast

$37.22

0.32 (0.87%)

CMCSK

Comcast

SNE

Sony

$37.55

0.11 (0.29%)

FOX

21st Century Fox

$26.84

0.14 (0.52%)

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

DIS

Disney

$99.40

0.39 (0.39%)

VIAB

Viacom

$26.70

0.17 (0.64%)

VIA

Viacom

$34.00

-0.05 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

SFNC

Simmons First National

$60.45

0.9 (1.51%)

18:16
10/22/17
10/22
18:16
10/22/17
18:16
Earnings
Simmons First National reports Q3 core EPS 86c, consensus 86c »

Reports Q3 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HLX

Helix Energy

$7.76

-0.13 (-1.65%)

18:09
10/22/17
10/22
18:09
10/22/17
18:09
Earnings
Helix Energy reports Q3 EPS 2c, consensus 2c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GM

General Motors

$45.61

0.26 (0.57%)

18:00
10/22/17
10/22
18:00
10/22/17
18:00
Periodicals
Driverless-car, emerging tech bets help GM shrug off 'dinosaur' image, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GOOG

Alphabet

$988.20

3.75 (0.38%)

, GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

17:42
10/22/17
10/22
17:42
10/22/17
17:42
Periodicals
Alphabet turns on internet balloons in Puerto Rico, AP says »

Alphabet's…

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

AAPL

Apple

$156.25

0.27 (0.17%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

17:30
10/22/17
10/22
17:30
10/22/17
17:30
Periodicals
Facebook, Google spending big money to lobby on Russia, Recode says »

Apple (AAPL), Amazon…

AAPL

Apple

$156.25

0.27 (0.17%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

FB

Facebook

$174.98

0.42 (0.24%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

, UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

17:26
10/22/17
10/22
17:26
10/22/17
17:26
Conference/Events
Union Bankshares to host special shareholder meeting »

Special Shareholder…

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 15

    Nov

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

, XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

17:23
10/22/17
10/22
17:23
10/22/17
17:23
Conference/Events
Xenith Bankshares to host special shareholder meeting »

Special Shareholder…

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ROKA

Roka Bioscience

$1.53

-0.24 (-13.56%)

17:20
10/22/17
10/22
17:20
10/22/17
17:20
Conference/Events
Roka Bioscience to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

17:03
10/22/17
10/22
17:03
10/22/17
17:03
Conference/Events
OceanFirst Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

, SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

16:57
10/22/17
10/22
16:57
10/22/17
16:57
Conference/Events
Sun Bancorp to host special shareholder meeting »

Special Shareholder…

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Oct

  • 15

    Nov

SGU

Star Gas Partners, L.P.

$10.52

-0.16 (-1.50%)

16:49
10/22/17
10/22
16:49
10/22/17
16:49
Conference/Events
Star Gas Partners, L.P. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETRM

EnteroMedics

$2.05

0.07 (3.54%)

16:44
10/22/17
10/22
16:44
10/22/17
16:44
Conference/Events
EnteroMedics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

, SSB

South State

$92.15

-0.2 (-0.22%)

16:39
10/22/17
10/22
16:39
10/22/17
16:39
Conference/Events
South State to host special shareholder meeting »

Special Shareholder…

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

SSB

South State

$92.15

-0.2 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

SSB

South State

$92.15

-0.2 (-0.22%)

, PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

16:36
10/22/17
10/22
16:36
10/22/17
16:36
Conference/Events
Park Sterling Bank to host special shareholder meeting »

Special Shareholder…

SSB

South State

$92.15

-0.2 (-0.22%)

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

, CARO

Carolina Financial

$36.17

0.23 (0.64%)

16:22
10/22/17
10/22
16:22
10/22/17
16:22
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

CARO

Carolina Financial

$36.17

0.23 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CARO

Carolina Financial

$36.17

0.23 (0.64%)

, FSBK

First South Bancorp

$18.66

0.14 (0.76%)

16:19
10/22/17
10/22
16:19
10/22/17
16:19
Conference/Events
First South Bancorp to host special shareholder meeting »

Special Shareholder…

CARO

Carolina Financial

$36.17

0.23 (0.64%)

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

13:41
10/22/17
10/22
13:41
10/22/17
13:41
Periodicals
Fox knew of new harassment settlement before signing O'Reilly, Reuters says »

Forced to resign in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TM

Toyota

$123.71

0.64 (0.52%)

13:37
10/22/17
10/22
13:37
10/22/17
13:37
Periodicals
Toyota to halt operations at Japan plants as typhoon approaches, Reuters says »

Toyota is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

, BAC

Bank of America

$27.17

0.59 (2.22%)

13:34
10/22/17
10/22
13:34
10/22/17
13:34
Hot Stocks
IntercontinentalExchange completes BofA Merrill's Index Platform acquisition »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

BAC

Bank of America

$27.17

0.59 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

VCYT

Veracyte

$9.30

0.11 (1.20%)

13:30
10/22/17
10/22
13:30
10/22/17
13:30
Hot Stocks
Veracyte announces new data, highlights Afirma GSC performance »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$63.88

0.13 (0.20%)

13:19
10/22/17
10/22
13:19
10/22/17
13:19
Hot Stocks
Study shows Merck Zepatier resulted in high sustained virologic response rates »

Merck has announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

  • 02

    Feb

EADSY

Airbus

$23.76

-0.135 (-0.56%)

, BDRBF

Bombardier

$2.25

0.04 (1.81%)

12:57
10/22/17
10/22
12:57
10/22/17
12:57
Periodicals
Airbus turmoil overshadows bid to rescue Bombardier CSeries, Reuters says »

Airbus's (EADSY)…

EADSY

Airbus

$23.76

-0.135 (-0.56%)

BDRBF

Bombardier

$2.25

0.04 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

, SPX

S&P 500

11:19
10/22/17
10/22
11:19
10/22/17
11:19
Periodicals
Senate Republican Leader says tax bill to be revenue neutral, Reuters reports »

Mitch McConnell said he…

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$15.56

0.31 (2.03%)

11:15
10/22/17
10/22
11:15
10/22/17
11:15
Periodicals
People use Snapchat at parties, not as much at sports stadiums, Recode says »

There seems to be a huge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.